JSAM
WVE icon

J. Safra Asset Management’s Wave Life Sciences WVE Stock Holding History

J. Safra Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-262
Closed -$4.45K – 675
2025
Q4 		$4.45K Buy
+262
New +$2.66K ﹤0.01% 445

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

J. Safra Asset Management's WVE Position: Q1 2026 in Review

J. Safra Asset Management sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 262 shares — an estimated $4.45K sold.

J. Safra Asset Management first reported a position in WVE in Q4 2025 and held it in 1 quarter. The position peaked at $4.45K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • J. Safra Asset Management reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • J. Safra Asset Management sold 262 Wave Life Sciences shares in Q1 2026, an estimated $4.45K.
  • J. Safra Asset Management first reported a position in Wave Life Sciences in Q4 2025 and held it in 1 quarter.
  • J. Safra Asset Management's Wave Life Sciences position peaked at $4.45K in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on J. Safra Asset Management's 13F filing for Q1 2026, filed 4 May 2026.